Clinical experience with use of ultrasound sphygmomanometer.
about
Moderate sodium restriction with angiotensin converting enzyme inhibitor in essential hypertension: a double blind study.Decreased plasma concentrations and clinical effects of alprenolol during combined treatment with pentobarbitone in hypertension.Prazosin first dose phenomenon during combined treatment with a beta-adrenoceptor blocker in hypertensive patients.Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction?Lack of effect of oral magnesium on high blood pressure: a double blind studyRelation between arterial pressure, dietary sodium intake, and renin system in essential hypertension.Evidence for a raised concentration of a circulating sodium transport inhibitor in essential hypertensionLack of effect of beta-blocker on flat dose response to thiazide in hypertension: efficacy of low dose thiazide combined with beta-blocker.Long term reduction in sodium balance: possible additional mechanism whereby nifedipine lowers blood pressure.Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London.Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents.Evidence for a new role of natriuretic peptides: control of intraocular pressure.The effect of oral digoxin on sodium excretion, renin-angiotensin-aldosterone system and blood pressure in normotensive subjects.Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjectsAutomated blood pressure determination during exercise test. Clinical evaluation of a new automated device.
P2860
Q34068900-7D898C54-6414-4084-860D-96609D388373Q34416708-2EFE5862-1C1D-4625-9237-DE4FF5FC0085Q34449933-1B59D955-EF8E-4FE5-9031-077DAFB7013AQ34484062-4A4A577A-EC49-49E7-B66F-B6942BAAA93AQ34487369-ABB8C000-0D02-4CAA-B6B1-AC7E0C1A364FQ34781422-A6157661-A9BA-4982-8718-D27844D417CAQ34785437-61704986-AB56-4583-894B-0487EA51BE18Q34992925-43C0C3C1-5E5B-4E4B-8542-F8BEB43D2CFAQ35170482-DAAA717A-A008-4C19-BBA5-F2F70579AF88Q35843174-2BC56C5F-E9C6-4B5E-8CF5-6AC8960E95E5Q36766560-A6D57FB0-24D2-48EA-8125-68E1343048FEQ37307181-A2D553E1-3ECF-48C3-9412-ECB84FD1BC0BQ38949335-D41E0ECE-9296-4B62-AB53-C3406062FE9DQ42354719-2E5E8C75-AAFB-40CD-AB3A-9130C6BB8F23Q43737255-C7D970D7-B18F-4A2A-9705-8CB8C4675BDD
P2860
Clinical experience with use of ultrasound sphygmomanometer.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Clinical experience with use of ultrasound sphygmomanometer.
@ast
Clinical experience with use of ultrasound sphygmomanometer.
@en
type
label
Clinical experience with use of ultrasound sphygmomanometer.
@ast
Clinical experience with use of ultrasound sphygmomanometer.
@en
prefLabel
Clinical experience with use of ultrasound sphygmomanometer.
@ast
Clinical experience with use of ultrasound sphygmomanometer.
@en
P2093
P356
P1476
Clinical experience with use of ultrasound sphygmomanometer.
@en
P2093
P2860
P304
P356
10.1136/HRT.37.8.804
P577
1975-08-01T00:00:00Z